Simultaneously, adding MG132 to inhibit the degradation of ATG9B caused by the reduction of MYH9 will restore a part of invasion, but it is still weaker than the control group, indicating that ATG9B depends on MYH9 to promote CRC invasion (Fig. 4N). This evidence concerns the gene MYH9 and colorectal carcinoma.